ARTICLE | Clinical News
Biojector 2000: Phase II started
June 2, 2008 7:00 AM UTC
The Centers for Disease Control and Prevention (CDC) began a Dominican Republican Phase II trial to evaluate Vaxigrip influenza vaccine delivered intradermally via Biojector 2000 or intramuscularly vi...